← Back to Search

CTNSM for Dehydration

N/A

Waitlist Available

Led By Natasha Solle, PhD

Research Sponsored by University of Miami

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 weeks

Awards & highlights

Study Summary

This trial is testing whether a text message intervention can help manage chemotherapy side effects and prevent dehydration.

Eligible Conditions

Dehydration
Symptom Clusters
Quality of Life
Self-Efficacy
Chemotherapy Side Effects

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in MDASI scores

Dehydration

Secondary outcome measures

Change in FACT-B Scores

Change in FACT-C Scores

Liquid Chromatography

+4 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CTNSM GroupExperimental Treatment2 Interventions

Culturally Tailored Nurse Symptom Management group (CTNSM) - participants in the CTNSM group will receive one in-person or telehealth face-to-face education session followed by a weekly telephone call and/or text message during the first 12 weeks of standard of care chemotherapy. In addition, participants can receive standard of care chemotherapy education.

Group II: Standard of Care (control) GroupActive Control1 Intervention

Participants in the control group will only be receiving the standard of care chemotherapy education.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CTNSM

2021

N/A

~40

Standard of Care Chemotherapy Education

2021

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor

898 Previous Clinical Trials

409,617 Total Patients Enrolled

1 Trials studying Dehydration

11 Patients Enrolled for Dehydration

Oncology Nursing SocietyOTHER

10 Previous Clinical Trials

465 Total Patients Enrolled

Natasha Solle, PhDPrincipal InvestigatorUniversity of Miami

1 Previous Clinical Trials

72 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the primary objectives of this medical experiment?

"The primary objective of this 12-week clinical trial is to investigate the effects of the treatment on dehydration. Additionally, changes in Partners in Health Scale (PIHS) scores, percentage of completed call or text messages and Chronic Disease Self-Efficacy Scale (CDSES) scores will be recorded as secondary outcomes. PIHS consists of twelve items with score range 0-8 per question that assesses symptom self management; CDSES comprises ten questions with a total score ranging from 0 - 10 which measures perceived self efficacy."

Answered by AI

Are any new participants being enrolled in this investigation?

"According to the clinicaltrials.gov website, this research experiment is actively recruiting participants; it was initially posted on September 23rd 2021 and modified most recently on September 27th 2022."

Answered by AI

What is the participant count of this trial?

"Affirmative. Clinicaltrials.gov reveals that the clinical trial, which was initially posted on September 23rd 2021, is currently recruiting participants. 98 patients must be sourced from a single location for successful completion of this study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Culturally Tailored Nurse Coaching Study for Cancer Symptom Management

Natasha Solle, PhD, RN 2021. "Culturally Tailored Nurse Coaching Study for Cancer Symptom Management". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04874584.